1. Express Scripts to cover AbbVie’s new Hepatitis C treatment but not Gilead’s Sovaldi
Click here.
2. FDA approves new hepatitis C treatment drug
Click here.
3. Hepatitis C burden expected to take a sharp downturn
Click here.
4. American Journal of Medicine launches HCV resource
Click here.
5. FDA approves combination drug Harvoni for HCV
Click here.
6. Gilead Sciences briefs Congress on cost of HCV drug
Click here.
7. HCV drug Sovaldi sales on the decline
Click here.
More articles on gastroenterology:
Adopting the updated GI procedure quality metrics & what this means for practice
Making the most of 2015: New Year’s resolutions in GI
10 most-read GI/endoscopy stories of 2014
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.